$350.34
Humana is a healthcare plans business based in the US. Humana shares (HUM.US) are listed on the NYSE and all prices are listed in US dollars. Its last market close was $349.50 – an increase of 0.32% over the previous day. Humana employs 67,600 staff and has a trailing 12-month revenue of around $106.4 billion.
How to buy shares in Humana
- Choose a platform. If you're a beginner, our stock trading platform picks below can help you choose.
- Open your account. Provide your personal information and sign up.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: HUM in this case.
- Research stocks. The platform should provide the latest information available.
- Buy your stocks. Place a market order or limit order with your preferred number of shares. It's that simple.
Our top picks for buying Humana stock
- Earn 5.25% interest on uninvested cash with Gold
- Get up to $50,000 in instant deposits with Gold
- Easy, user-friendly trading
- Trade stocks, bonds, options, ETFs, crypto, Treasurys, collectibles, royalties
- Earn 5.1% APY on your cash
- Earn a $0.18 rebate on options, with no commissions and no per-contract fees
- Trade stocks, options and ETFs without commissions
- Innovative social trading features
- FINDER EXCLUSIVE: Get a guaranteed $15 bonus when you sign up and deposit $100
Is it a good time to buy Humana stock?
Only you can make the decision on the time to leap... but here's some supporting information and analysis.
Share price volatility
Over the last 12 months, Humana's shares have ranged in value from as little as $334.54 up to $538.1077. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Humana's is 0.453. This would suggest that Humana's shares are less volatile than average (for this exchange).
Historical closes compared with the last close of $349.5
1 week (2024-03-20) | 0.61% |
---|---|
1 month (2024-02-27) | -0.47% |
3 months (2023-12-27) | -23.29% |
6 months (2023-09-27) | -29.42% |
1 year (2023-03-27) | -27.70% |
2 years (2022-03-24) | -19.75% |
3 years (2021-03-25) | -17.49% |
5 years (2019-03-27) | 33.09% |
The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.
Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.
Buy Humana stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is Humana under- or over-valued?
Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value. Check out the Humana P/E ratio, PEG ratio and EBITDA
Humana's current stock price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 17x. In other words, Humana stocks trade at around 17x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the United States stock markets on average as of November 09, 2023 (20.44). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Humana's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.4439. A PEG ratio over 1 can be interpreted as meaning shares are overvalued at the current rate of growth, or may anticipate an acceleration in growth.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Humana's future profitability. By accounting for growth, it could also help you if you're comparing the stock prices of multiple high-growth companies.
Humana's EBITDA (earnings before interest, taxes, depreciation and amortisation) is a whopping $4.9 billion.
The EBITDA is a measure of a Humana's overall financial performance and is widely used to measure a its profitability.
Frequently asked questions
More guides on Finder
-
How to buy Zentek stock
Steps to owning and managing ZTEK, with 24-hour and historical pricing before you buy.
-
How to buy Mainz Biomed stock
Steps to owning and managing MYNZ, with 24-hour and historical pricing before you buy.
-
How to buy ATAI Life Sciences stock
Steps to owning and managing ATAI, with 24-hour and historical pricing before you buy.
-
How to buy Owlet Baby Care stock
Steps to owning and managing OWLT, with 24-hour and historical pricing before you buy.
-
How to buy Eli Lilly and Company stock
Steps to owning and managing LLY, with 24-hour and historical pricing before you buy.
-
How to buy Illumina stock
Steps to owning and managing ILMN, with 24-hour and historical pricing before you buy.
-
How to buy UnitedHealth Group Incorporated stock
Steps to owning and managing UNH, with 24-hour and historical pricing before you buy.
-
How to buy Pfizer stock
Steps to owning and managing PFE, with 24-hour and historical pricing before you buy.
-
How to buy Johnson-and-Johnson stock
Steps to owning and managing JNJ, with 24-hour and historical pricing before you buy.
Ask a Question